Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
- DOI
- 10.1001/jamaneurol.2024.5249
- Published
- 2025 Apr
- Container
- JAMA neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaneurol.2024.5249,
title = {Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.},
author = {Writing Committee for the HEALEY ALS Platform Trial and Andrews J and Paganoni S and Macklin EA and Chibnik LB and Quintana M and Saville BR and Detry MA and Vestrucci M and Marion J and McGlothlin A and Young E and Chase M and Pothier L and Harkey B and Yu H and Sherman A and Shefner J and Hall M and Kittle G and Connolly MR and Berry JD and D'Agostino D and Tustison E and Giacomelli E and Scirocco E and Alameda G and Locatelli E and Ho D and Quick A and Heitzman D and Ajroud-Driss S and Appel SH and Shroff S and Katz J and Felice K and Maragakis NJ and Simmons Z and Goutman SA and Olney N and Miller T and Fernandes JA and Ilieva H and Jawdat O and Weiss MD and Foster L and Vu T and Ladha S and Owegi MA and Newman DS and Arcila-Londono X and Jackson CE and Swenson A and Heiman-Patterson T and Caress J and Fee D and Peltier A and Lewis R and Rosenfeld J and Walk D and Johnson K and Elliott M and Kasarskis EJ and Rutkove S and McIlduff CE and Bedlack R and Elman L and Goyal NA and Rezania K and Twydell P and Benatar M and Glass J and Cohen JA and Jones V and Zilliox L and Wymer JP and Beydoun SR and Shah J and Pattee GL and Martinez-Thompson J and Nayar S and Granit V and Donohue M and Grossman K and Campbell DJ and Qureshi IA and Cudkowicz ME and Babu S},
year = {2025},
journal = {JAMA neurology},
doi = {10.1001/jamaneurol.2024.5249},
url = {https://doi.org/10.1001/jamaneurol.2024.5249}
}RIS
TY - JOUR TI - Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial. AU - Writing Committee for the HEALEY ALS Platform Trial AU - Andrews J AU - Paganoni S AU - Macklin EA AU - Chibnik LB AU - Quintana M AU - Saville BR AU - Detry MA AU - Vestrucci M AU - Marion J AU - McGlothlin A AU - Young E AU - Chase M AU - Pothier L AU - Harkey B AU - Yu H AU - Sherman A AU - Shefner J AU - Hall M AU - Kittle G AU - Connolly MR AU - Berry JD AU - D'Agostino D AU - Tustison E AU - Giacomelli E AU - Scirocco E AU - Alameda G AU - Locatelli E AU - Ho D AU - Quick A AU - Heitzman D AU - Ajroud-Driss S AU - Appel SH AU - Shroff S AU - Katz J AU - Felice K AU - Maragakis NJ AU - Simmons Z AU - Goutman SA AU - Olney N AU - Miller T AU - Fernandes JA AU - Ilieva H AU - Jawdat O AU - Weiss MD AU - Foster L AU - Vu T AU - Ladha S AU - Owegi MA AU - Newman DS AU - Arcila-Londono X AU - Jackson CE AU - Swenson A AU - Heiman-Patterson T AU - Caress J AU - Fee D AU - Peltier A AU - Lewis R AU - Rosenfeld J AU - Walk D AU - Johnson K AU - Elliott M AU - Kasarskis EJ AU - Rutkove S AU - McIlduff CE AU - Bedlack R AU - Elman L AU - Goyal NA AU - Rezania K AU - Twydell P AU - Benatar M AU - Glass J AU - Cohen JA AU - Jones V AU - Zilliox L AU - Wymer JP AU - Beydoun SR AU - Shah J AU - Pattee GL AU - Martinez-Thompson J AU - Nayar S AU - Granit V AU - Donohue M AU - Grossman K AU - Campbell DJ AU - Qureshi IA AU - Cudkowicz ME AU - Babu S PY - 2025 JO - JAMA neurology DO - 10.1001/jamaneurol.2024.5249 UR - https://doi.org/10.1001/jamaneurol.2024.5249 ER -
APA
Trial, W. C. F. T. H. A. P., J, A., S, P., EA, M., LB, C., M, Q., BR, S., MA, D., M, V., J, M., A, M., E, Y., M, C., L, P., B, H., H, Y., A, S., J, S., M, H., G, K., MR, C., JD, B., D, D., E, T., E, G., E, S., G, A., E, L., D, H., A, Q., D, H., S, A., SH, A., S, S., J, K., K, F., NJ, M., Z, S., SA, G., N, O., T, M., JA, F., H, I., O, J., MD, W., L, F., T, V., S, L., MA, O., DS, N., X, A., CE, J., A, S., T, H., J, C., D, F., A, P., R, L., J, R., D, W., K, J., M, E., EJ, K., S, R., CE, M., R, B., L, E., NA, G., K, R., P, T., M, B., J, G., JA, C., V, J., L, Z., JP, W., SR, B., J, S., GL, P., J, M., S, N., V, G., M, D., K, G., DJ, C., IA, Q., ME, C., & S, B. (2025). Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.. JAMA neurology. https://doi.org/10.1001/jamaneurol.2024.5249
Source records
- pubmed · retrieved 2026-09-26T06:46:28.447Z